English 
Spanish 
Arabic 
Chinese 
French 
DBL™ buttock contouring · Tissue planes and product location
The buttock is not one uniform space that can simply be “filled”. Skin, two subcutaneous compartments, superficial fascia, deep fascia and muscle form distinct but connected layers, while important blood vessels and nerves travel through the region. In DBL™ planning, the question is therefore not only how much volume might be considered, but where a contour change originates, where product is intended to sit and whether previous material has altered the normal anatomy.
The essential idea
Product location is part of both the aesthetic plan and the safety plan. A surface hollow does not identify the correct tissue layer by itself. Placement that is too superficial may show through or form irregularities; unintended deeper or intravascular placement can expose major structures and cause serious harm. UK expert guidance treats injectable buttock augmentation as a high-risk invasive procedure and identifies subcutaneous, ultrasound-guided product placement as a safety standard—not a guarantee that complications cannot occur.
A three-dimensional region, not a flat outline
External shape is created by the pelvis, gluteal muscles, regional fat, fibrous attachments and the skin envelope. These elements change across the upper, central, lateral and lower buttock and continue into the flanks, trochanteric region and posterior thigh. The left and right sides are not mirror images, even before any procedure.
That matters because requests such as “more projection”, “rounder sides” or “a smoother transition” describe an appearance, not an anatomical target. Projection created by muscle, a lateral hollow influenced by skeletal width and an indentation caused by scar tethering cannot be treated as versions of the same volume deficit. Adding product may soften a selected transition, but it cannot narrow the pelvis, strengthen muscle, remove loose skin or guarantee symmetry.
Framework
Pelvis and landmarks
Bony width and the greater trochanter influence the outer contour but cannot be repositioned by filler.
Dynamic form
Muscle and posture
Gluteal contraction, pelvic position and weight-bearing alter the shape seen in a static photograph.
Soft-tissue envelope
Fat, fascia and skin
Thickness, laxity, fibrous attachments and scars affect coverage and how an added material may appear.
Structures at risk
Vessels and nerves
Major gluteal vessels and the sciatic nerve lie in deeper anatomy, while smaller vessels also cross superficial tissue.
The main tissue layers beneath the buttock surface
Anatomical and ultrasound literature describes the region from superficial to deep as skin, subcutaneous tissue, superficial fascia, deeper subcutaneous tissue, deep muscular fascia, gluteal muscle and deeper neurovascular and bony structures. The subcutaneous layer itself is not homogeneous: a more superficial areolar compartment and a deeper lamellar compartment are separated by the superficial fascia.
| Layer or structure | Contribution to the visible contour | Why it matters clinically |
|---|---|---|
| Skin and dermis | Thickness, elasticity, scars and stretch affect how underlying changes show at the surface. | Thin or lax coverage can make edges, lumps and irregular distribution more visible. |
| Superficial subcutaneous compartment | Fat lobules and fibrous connections contribute to surface smoothness and local fullness. | Its depth varies; overly superficial material may become palpable or visible. |
| Superficial fascia | A connective-tissue boundary that helps organise the superficial and deep fat compartments. | It is not a perfectly flat sheet; its continuity and attachments affect how product may spread. |
| Deep subcutaneous compartment | Provides part of the soft-tissue volume above the muscular fascia. | Published UK expert guidance restricts buttock augmentation product to the subcutaneous plane. |
| Deep fascia and muscle | Muscle supplies dynamic projection and changes with contraction and position. | The muscle is more vascular than subcutaneous fat and is not an acceptable filler destination under the cited UK guidance. |
| Deep vessels, nerves and bone | They do not represent a cosmetic volume target. | The superior and inferior gluteal vessels and sciatic nerve make unintended deep placement potentially catastrophic. |
This is an educational map, not a set of injection instructions. Living anatomy varies, layers curve and change thickness, and vessels can travel outside textbook averages. Knowing the names of the planes is not equivalent to being able to assess or treat them safely.
Why the surface target does not choose the plane
A visible depression can arise from a regional lack of soft-tissue volume, a fibrous tether, unequal fat thickness, scar contraction, pelvic structure or a combination. A prominent area may reflect muscle, fat, swelling or existing product. The surface appearance cannot reliably show which layer is responsible.
The intended correction also changes how the plan is judged. Softening a transition across a broad lateral zone is different from addressing a narrow indentation. Trying to create substantial projection where tissue coverage is limited is different from balancing a minor side-to-side volume difference. In each case, product volume, distribution and tissue capacity interact; more material does not automatically produce a more controlled result.
We assess the buttocks standing and compare relevant positions because gravity and muscle engagement change the contour. We also look beyond the marked hollow. A plan that fills only the deepest point can create an isolated mound or an abrupt edge rather than a continuous transition. Conversely, spreading product widely without a defined target can add volume without correcting the feature that prompted consultation.
How product location changes behaviour and risk
Hyaluronic acid filler is a medical device placed into living tissue. Its location affects whether it is visible or palpable, how it integrates and spreads, how pressure and movement act on it, how easily it may be assessed later and which structures are exposed if placement is unintended. Product characteristics and quantity matter, but they do not make anatomical location irrelevant.
| Location finding | Possible consequence | Planning implication |
|---|---|---|
| Very superficial material | Visible edges, nodules, uneven texture, altered skin movement or inflammation may be more apparent. | Coverage and skin quality must be considered; adding more product may worsen rather than camouflage the problem. |
| Subcutaneous material in the intended region | May support a planned contour change, while still carrying risks of infection, migration, inflammation and irregularity. | Correct plane alone does not prove that the product, amount, target or overall procedure is appropriate. |
| Product crossing compartments | Material may track through access paths, fascial discontinuities or scarred tissue and create a contour away from the original target. | Distribution should be assessed rather than assuming that every palpable area is the original deposit. |
| Intramuscular or otherwise unintended deep material | Exposure to more vascular anatomy, pain, functional symptoms and difficult assessment or management. | Further cosmetic injection should not proceed on assumption; imaging, records or specialist assessment may be required. |
| Intravascular entry | Vascular occlusion, tissue injury or embolic complications that may be life-threatening. | This is a medical emergency risk; anatomy knowledge, ultrasound guidance and emergency capability are essential but cannot reduce risk to zero. |
The October 2024 JCCP guidance, developed with UK professional stakeholders, considers augmentation of the buttocks with dermal filler surgical in nature. It states that the restriction of fat injection to the subcutaneous plane also applies to soft-tissue fillers and identifies ultrasound-guided product placement to confirm depth and plane as a national safety standard for buttock augmentation.
Ultrasound guidance does not convert DBL™ into a low-risk beauty treatment. It sits within a wider system that includes appropriate practitioner competence, clinical premises, asepsis, product selection, assessment, consent, emergency resources and follow-up.
Previous product can rewrite the anatomical map
Filler does not always remain as one neat deposit. Its ultrasound appearance and distribution depend on the material, time, surrounding tissue and previous interventions. Product can be superficial or deep, localised or dispersed, and may coexist with fibrosis, fluid, inflammation, fat transfer, an implant or another filler type. A scarred access route can also alter how tissue separates and how future material might spread.
Identity
What was injected?
Brand, composition, batch, volume and treatment date matter. “Body filler” is not an adequate medical record.
Distribution
Where is it now?
The current location may differ from the marked target or from what is remembered about the original procedure.
Tissue response
How has the body reacted?
Pain, heat, swelling, nodules, drainage, skin change or a collection may require a medical pathway rather than more contouring.
Interaction
What would new product meet?
Unknown or permanent material, an implant, fat grafts or fibrosis can make a new injectable plan uncertain or inappropriate.
We ask for treatment records even when the procedure occurred years ago or abroad. If the product is unknown, the absence of symptoms does not establish that it is safe to inject around it. Our current procedure information lists a history of complications after permanent gluteal products among contraindications to product injection.
Hyaluronic acid may sometimes be treated with hyaluronidase, but “dissolvable” does not mean that every deposit is easy to reach or that every complication can be reversed. Dissolution can be incomplete and cannot undo vascular injury, infection, tissue loss, scarring or all contour changes. It is a separate medical decision, not a routine reset before adding more filler.
What ultrasound can—and cannot—establish
Our DBL™ procedure information explains that the doctor may perform an ultrasound scan to assess anatomy, locate blood vessels, review previous filler and check anatomical variation. Whether imaging is required and how it is used depend on the individual case and proposed plan.
High-frequency ultrasound can show superficial layers, while lower-frequency equipment can assess deeper structures. Colour Doppler can add information about blood flow. A 2025 descriptive study of 110 patients proposed systematic ultrasound mapping of the gluteal region and reported that imaging could help characterise several filler materials and their distribution. Earlier specimen research also showed that different injectables and even different products within a category can have different dispersion appearances.
Imaging is valuable precisely because touch and surface inspection cannot reliably establish depth. It still has boundaries: appearances can overlap, diffuse material can be difficult to quantify, a scan may not identify an unknown substance with certainty, and anatomy changes as the probe, person and tissue move. Ultrasound does not certify that a large-volume injection will be complication-free.
A clear scan does not replace the rest of the safety system
Product location is only one decision. Medical history, previous reactions, infection risk, bleeding and clotting, product instructions, treatment scale, sterile technique, emergency preparedness, informed consent and aftercare remain necessary. Ultrasound supports judgement; it does not supply suitability on its own.
From anatomical assessment to a DBL™ plan
DBL™ / Ducu Butt Lift is our doctor-led buttock contouring procedure using hyaluronic acid-based dermal filler placed with a cannula according to an individual plan. Product choice, amount and treatment zones are considered only after anatomy, medical history, skin quality, previous procedures and expectations have been reviewed.
| Assessment finding | Possible decision | What the decision does not promise |
|---|---|---|
| Defined subcutaneous volume target with adequate coverage | A limited or staged DBL™ plan may be discussed, subject to the full risk assessment. | It does not guarantee a particular size, perfect symmetry or a complication-free procedure. |
| Thin, lax or uneven soft-tissue coverage | The requested scale may be reduced, staged, redirected or declined. | Filler cannot remove skin excess or guarantee that edges and irregularities will not show. |
| Reliable history but existing product present | Records and imaging may be reviewed before any decision about additional treatment. | Compatibility, location and future behaviour cannot be inferred from the absence of current symptoms. |
| Unknown material, altered deep plane or complication | Treatment may be deferred or declined and another medical or surgical assessment recommended. | More filler is not an automatic correction for pain, inflammation, migration or tissue damage. |
| Goal depends mainly on bone, muscle or substantial skin excess | An alternative or no treatment may be more anatomically honest. | Product cannot change skeletal proportions, build muscle or excise excess skin. |
Our current procedure information gives an indicative appointment time of approximately two hours and explains that multiple sessions may sometimes be required. These are not reasons to assume a standard volume or a standard map. Staging may allow tissue response and contour to be reviewed, but each session carries its own risks.
GMC guidance requires doctors offering cosmetic interventions to discuss benefits, material risks, reasonable alternatives and the option of no treatment, allow time for reflection and take responsibility for continuity of care. A consultation may result in a different plan or a decision not to proceed.
Complications and warning signs
Expected short-term effects can include swelling, bruising, tenderness, redness, entry marks, temporary numbness and early asymmetry. More serious or persistent complications include infection, abscess, bleeding, haematoma, prolonged swelling, nodules, filler migration, granuloma, inflammatory or allergic reaction, contour irregularity, scarring, delayed healing, tissue damage, skin necrosis, vascular occlusion and embolic events. Hospital treatment or surgery may be required.
The 2023 systematic review of hyaluronic acid gluteal augmentation found only ten eligible reports covering 168 patients. It described bruising and erythema, effusion, inflammation, product dislocation, irregular contours and major complications, including one death. Small observational studies cannot establish the personal risk of DBL™ or the long-term behaviour of every large-volume body filler.
Symptoms that require urgent action
Contact the treating team urgently for severe or rapidly worsening pain, one-sided or expanding swelling, persistent bleeding, spreading redness, fever, pus, increasing warmth, a new collection, marked colour change, blistering, cold or pale skin, new weakness or significant altered sensation.
Call 999 for sudden breathlessness, chest pain, collapse, confusion, weakness affecting one side, difficulty speaking or another life-threatening symptom. Do not wait for a routine review or attempt to massage the area.
Frequently asked questions
What is a tissue plane?
It is an anatomical layer or interface between structures, such as the superficial and deep subcutaneous compartments separated by fascia. Planes are three-dimensional, variable and crossed by vessels; they are not perfectly flat spaces.
Which plane should buttock filler be placed in?
Current JCCP expert guidance for UK enforcement states that the restriction to subcutaneous placement applies to soft-tissue filler used for buttock augmentation. The individual subcutaneous map still requires clinical and ultrasound assessment.
Why is intramuscular filler placement a concern?
Gluteal muscle is more vascular than subcutaneous fat and lies near major neurovascular structures. Unintended deep placement may increase the risk of serious injury and can make later assessment or management more difficult.
Can the correct tissue plane be identified by touch alone?
Surface examination and palpation provide useful information but cannot reliably show every vessel, fascial boundary or previous filler deposit. UK expert guidance identifies ultrasound-guided placement as a safety standard for buttock augmentation.
Does ultrasound make DBL™ risk-free?
No. Ultrasound can help assess anatomy, vessels, depth and previous material, but it cannot prevent every complication or replace appropriate competence, asepsis, product selection, emergency preparedness and aftercare.
Can ultrasound confirm exactly which filler is present?
Not always. Different substances can have characteristic appearances, but patterns may overlap and change with time or tissue response. Original product records remain important, and further assessment may be required.
Why can superficial filler become visible or lumpy?
Limited skin and fat coverage can make product edges, uneven distribution, inflammation or nodules easier to see or feel. Product type, quantity, tissue response and location all influence the result.
Can filler move from the original treatment area?
Migration or spread can occur. Material may follow tissue pathways, pressure gradients, access routes or areas changed by scarring. A new lump or contour change should be assessed rather than assumed to be harmless movement.
Does a blunt cannula eliminate vascular risk?
No. A cannula is used to reduce some forms of trauma, but it does not make vascular entry, tissue injury or embolic complications impossible. Plane control and the wider safety system remain essential.
Can more product correct a filler irregularity?
Not automatically. If the problem is superficial product, migration, inflammation, scar tissue, infection or an altered plane, adding filler may conceal the cause temporarily or make management more difficult.
Does limited body fat prevent DBL™?
Not in every case, because DBL™ does not require donor fat. However, limited subcutaneous coverage may affect product visibility, contour transitions and the amount that can reasonably be considered.
Can previous liposuction change the injection plane?
Yes. Uneven fat thickness, fibrosis and scar adherence can distort normal planes and affect how an instrument or product moves. Records, examination and imaging may be needed before any further procedure is considered.
Can DBL™ be planned around a buttock implant?
It is not an automatic option. Implant type and position, the operative history, symptoms and surrounding tissue must be understood. A suspected implant complication requires appropriate surgical assessment, not filler camouflage.
Can hyaluronic acid filler always be completely dissolved?
No. Access and response depend on product identity, location, distribution and tissue reaction. Hyaluronidase also has its own risks, and dissolution cannot reverse infection, vascular injury, scarring or tissue loss.
Why might a DBL™ plan be staged?
Staging may limit the first intervention and allow tissue response, product distribution and contour to be reviewed before another decision. It does not make any injection session risk-free or guarantee that more product will be advised.
Anatomy-led consultation
Discuss the target, the tissue plane and the limits before deciding
We can assess the contour in three dimensions, review previous procedures and product records, consider whether ultrasound is required and explain why treatment, a modified plan, another pathway or no procedure may be appropriate.
Medical and regulatory sources consulted
- Dr Ducu Clinics — Non-Surgical BBL / DBL™ in London
- JCCP, CIEH and British Beauty Council — Buttock augmentation and other body contouring procedures guidance (2024)
- Reviewing the Ultrasound Anatomy of the Gluteal Region and the Mapping of Fillers (2025)
- Dynamic ultrasound evaluation of body fillers and biostimulators in the buttocks
- Systematic review of hyaluronic acid injections for gluteal augmentation
- Danger zones of the gluteal anatomy and tissue-dependent vascularity
- Gluteal ligamentous anatomy and implications for buttock augmentation
- General Medical Council — Guidance for doctors who offer cosmetic interventions
- Advertising Standards Authority — Cosmetic interventions advertising guidance
- NHS — Choosing who will do your cosmetic procedure